Algorithm for the evaluation of therapeutic failure reports-proposal and pilot analysis

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 2, 2013, Pages 199-206

  González, Claudia Patricia Vaca ^a   Martínez, Roxana Patricia De las salas ^b   Gutiérrez, José Julián López ^a   Pedraza, Ricardo Sánchez ^a   Figueras, Albert ^c  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

^b UNIVERSIDAD DEL NORTE   (Colombia)

^c Fundacion Institut Catala de Farmacologia   (Spain)

Author keywords

Algorithm; Causality; Pharmacoepidemiology; Pharmacovigilance; Rational drug use

Indexed keywords

ALGORITHM; ARTICLE; CLINICAL PHARMACOLOGY; DELPHI STUDY; DRUG MARKETING; DRUG MISUSE; DRUG SURVEILLANCE PROGRAM; HEALTH PRACTITIONER; INTRARATER RELIABILITY; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT FAILURE; VALIDITY;

ALGORITHMS; HUMANS; PHARMACOVIGILANCE; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT FAILURE;

EID: 84873416656     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3355     Document Type: Article

References (19)

1. Figueras A, Pedrós C, Valsecia M, Laporte JR. Therapeutic Ineffectiveness: Heads or Tails? Drug Saf 2002; 25: 485-87.
2. Meyboom R, Lindquist M, Flygare AK, Biriell C, Edwards R. The Value of Reporting Therapeutic Ineffectiveness as an Adverse Drug Reaction Drug Safety 2000; 23: 95-99.
3. World Health Organization. The Importance of Pharmacovigilance. In Safety Monitoring of Medicinal Product. World Health Organization: United Kingdom, 2002.
4. Olsson S, Edwards IR. The WHO international drug monitoring programme. In Side Effects of Drugs Annual, Aronson JK (ed.). Elsevier: Amsterdam, The Netherlands; 2000; 524-29.
5. Hallas J, Harvald B, Gram L, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990; 228: 83-90.
6. Franceschi A, Tuccori M, Bocci G, et al. Drug therapeutic failures in emergency department patients: A university hospital experience. Pharmacol Res 2004; 49: 85-91.
7. Ministerio de Salud Pública y Asistencia Social de Guatemala. Informe del Programa Nacional de Farmacovigilancia. In, Guatemala: Ministerio de Salud Pública y Asistencia Social, 2007.
8. ANMAT. Datos de Fallo Terapéutico en Argentina. In, Buenos Aires: ANMAT, 2009.
9. INVIMA. Datos de Fallo Terapéutico en Colombia. In, Bogotá DC: INVIMA, 2009.
10. Red PARF. Recomendaciones de la V Conferencia de la Red Panamericana para la Armonización de la Reglamentación Farmacéutica sobre el marco para la ejecución de los requisitos de equivalencia para los productos farmacéuticos. In, Buenos Aires: Organización Panamericana de la Salud PAHO/OPS, 2008: 43.
11. Linstone HA, Turoff M. The Delphi Method: Techniques and Applications: Addison-Wesley. Newark, New Jersey; 2002.
12. Black N, Murphy M, Lamping D, et al. Consensus development methods: a review of best practice in creating clinical guidelines. J Health Serv Res Policy 1999; 4: 236-48.
13. Cicchetti DV, Fleiss JL. Comparison of the Null Distributions of Weighted Kappa and the C Ordinal Statistic. Appl Psychol Meas 1977; 1: 195-201.
14. Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971; 76: 378-82.
15. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-74.
16. Fleiss JL. Statistical Methods for Rates and Proportions. (3rd edn.) New York John Wiley and Sons: New York; 2003.
17. Rycroft-Malone J. Formal consensus: the development of a national clinical guideline. Qual Health Care 2001; 10: 238-44.
18. Naranjo C, Busto U, Sellers E, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-45.
19. Kramer M, Leventhal J, Hutchinson T, Feinstein A. An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use. JAMA 1979; 242: 623-32.